Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer

2015

Background Enzalutamide is a novel antiandrogen with proven efficacy in metastatic castration-resistant prostate cancer (mCRPC).

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

28

References

176

Citations